SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-056066
Filing Date
2020-05-04
Accepted
2020-05-04 12:28:21
Documents
2
Period of Report
2020-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2018429-1_form4.html 4  
1 FORM 4 tm2018429-1_form4.xml 4 3280
2 EXHIBIT 24 tm2018429-1_ex24.htm EX-24 7442
  Complete submission text file 0001104659-20-056066.txt   12327
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 489 5TH AVE., 28TH FLOOR NEW YORK NY 10017
Business Address
Backenroth Samuel (Reporting) CIK: 0001579887 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 20843691